Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Urinary vitamin D binding protein loss as a potential biomarker for diabetic nephropathy in patients at risk for type 2 diabetes.
FY 2016-17
Summary
While there are a number of complications associated with type 2 diabetes, diabetic kidney disease is a major cause of illness and death in these patients. Multiple studies have shown that patients with diabetes tend to have lower levels of vitamin D, although the reason is currently unknown. Since many patients with diabetes also tend to have kidney problems, one possibility for low vitamin D status is loss of this vitamin through the urine. Recently, the vitamin D binding protein (VDBP) has been detected as one of the proteins spilled when there is kidney damage. Since the VDBP carries about 85% of the available vitamin D in circulation, this discovery raises the novel idea that renal excretion of VDBP is pulling out and lowering serum levels of vitamin D. However, there is limited research on the effect of urinary VDBP loss on vitamin D status, and no papers to date have studied urinary VDBP concentrations across a broad range of glucose tolerance and kidney dysfunction. The objectives of this study are to examine the associations of uVDBP concentrations with the severity of kidney dysfunction, the degree of glucose tolerance, and serum 25(OH)D concentrations, as well to as assess the predictive ability of early uVDBP loss on the development of kidney disease. Data for the project is derived from the Prospective Metabolism and Islet Cell Evaluation (PROMISE) cohort study. Biomarkers of interest include serum 25(OH)D, blood glucose, serum creatinine, uVDBP, urinary albumin, and urinary creatinine. Findings will indicate whether renal excretion of VDBP could be partially responsible for the lower levels of vitamin D in T2DM, and whether early loss of this protein is linked to later development of diabetic nephropathy.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
367400
Name
Wang Zhengnan
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Urinary vitamin D binding protein loss as a potential biomarker for diabetic nephropathy in patients at risk for type 2 diabetes.
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Diabetes; Dysglycemia; Kidney; Nephropathy; Urinary Vitamin D Binding Protein; Vitamin D
Abstract
While there are a number of complications associated with type 2 diabetes, diabetic kidney disease is a major cause of illness and death in these patients. Multiple studies have shown that patients with diabetes tend to have lower levels of vitamin D, although the reason is currently unknown. Since many patients with diabetes also tend to have kidney problems, one possibility for low vitamin D status is loss of this vitamin through the urine. Recently, the vitamin D binding protein (VDBP) has been detected as one of the proteins spilled when there is kidney damage. Since the VDBP carries about 85% of the available vitamin D in circulation, this discovery raises the novel idea that renal excretion of VDBP is pulling out and lowering serum levels of vitamin D. However, there is limited research on the effect of urinary VDBP loss on vitamin D status, and no papers to date have studied urinary VDBP concentrations across a broad range of glucose tolerance and kidney dysfunction. The objectives of this study are to examine the associations of uVDBP concentrations with the severity of kidney dysfunction, the degree of glucose tolerance, and serum 25(OH)D concentrations, as well to as assess the predictive ability of early uVDBP loss on the development of kidney disease. Data for the project is derived from the Prospective Metabolism and Islet Cell Evaluation (PROMISE) cohort study. Biomarkers of interest include serum 25(OH)D, blood glucose, serum creatinine, uVDBP, urinary albumin, and urinary creatinine. Findings will indicate whether renal excretion of VDBP could be partially responsible for the lower levels of vitamin D in T2DM, and whether early loss of this protein is linked to later development of diabetic nephropathy.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Wang, Zhengnan
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~